1938年至2013年的药物研发与美国食品药品监督管理局（FDA）批准情况 - Suppr

Suppr

超能文献

Drug development and FDA approval, 1938-2013.

作者信息

Darrow Jonathan J, Kesselheim Aaron S

出版信息

N Engl J Med. 2014 Jun 26;370(26):e39. doi: 10.1056/NEJMp1402114.

DOI:10.1056/NEJMp1402114

PMID:24963591

Abstract

摘要

相似文献

Drug development and FDA approval, 1938-2013.

N Engl J Med. 2014 Jun 26;370(26):e39. doi: 10.1056/NEJMp1402114.

Teaching clinicians about drugs--50 years later, whose job is it?

N Engl J Med. 2011 Mar 31;364(13):1185-7. doi: 10.1056/NEJMp1011713.

A history of drug development in four acts.

Drug Discov Today. 2015 Oct;20(10):1163-8. doi: 10.1016/j.drudis.2015.04.003. Epub 2015 Apr 20.

A long and winding road; evolution of antimicrobial drug development - crisis management.

Expert Rev Anti Infect Ther. 2012 Nov;10(11):1311-9. doi: 10.1586/eri.12.131.

Direct-to-consumer prescription drug advertising: history, regulation, and issues.

Minn Med. 2010 Mar;93(3):50-2.

Food and Drug Administration Drug Approval Process: A History and Overview.

Nurs Clin North Am. 2016 Mar;51(1):1-11. doi: 10.1016/j.cnur.2015.10.007. Epub 2016 Jan 13.

Déjà Vu at the FDA.

Milbank Q. 2017 Jun;95(2):245-248. doi: 10.1111/1468-0009.12252. Epub 2017 Apr 4.

Access before approval--a right to take experimental drugs?

N Engl J Med. 2006 Aug 3;355(5):437-40. doi: 10.1056/NEJMp068132.

Food and Drug Administration centennial: recognizing the guardians of our drug supply.

Arthritis Rheum. 2006 Oct;54(10):3374. doi: 10.1002/art.22144.

Food and Drug Administration approval of laboratory tests.

Arch Pathol Lab Med. 2013 Jan;137(1):13-8. doi: 10.5858/arpa.2012-0077-ED.

引用本文的文献

Drug repurposing: a promising drug discovery strategy for the treatment of emerging epidemic infectious disease.

Mol Divers. 2025 Jul 3. doi: 10.1007/s11030-025-11247-x.

Measuring and Understanding Market Exclusivity Length for New Prescription Drugs in France, Australia, and the USA.

Pharmaceut Med. 2024 Jul;38(4):303-310. doi: 10.1007/s40290-024-00527-w. Epub 2024 Jul 14.

Estimated Research and Development Investment Needed to Bring a New Medicine to Market, 2009-2018.

JAMA. 2020 Mar 3;323(9):844-853. doi: 10.1001/jama.2020.1166.

Characterization of Resistance in Gram-Negative Urinary Isolates Using Existing and Novel Indicators of Clinical Relevance: A 10-Year Data Analysis.

Life (Basel). 2020 Feb 11;10(2):16. doi: 10.3390/life10020016.

Public sector financial support for late stage discovery of new drugs in the United States: cohort study.

BMJ. 2019 Oct 23;367:l5766. doi: 10.1136/bmj.l5766.

Antibiotic Resistance: From the Bench to Patients.

Antibiotics (Basel). 2019 Aug 27;8(3):129. doi: 10.3390/antibiotics8030129.

The Concept of an Ideal Antibiotic: Implications for Drug Design.

Molecules. 2019 Mar 3;24(5):892. doi: 10.3390/molecules24050892.

Prediction of Drug-Likeness Using Deep Autoencoder Neural Networks.

Front Genet. 2018 Nov 27;9:585. doi: 10.3389/fgene.2018.00585. eCollection 2018.

The Comparative Effectiveness of Innovative Treatments for Cancer (CEIT-Cancer) project: Rationale and design of the database and the collection of evidence available at approval of novel drugs.

Trials. 2018 Sep 19;19(1):505. doi: 10.1186/s13063-018-2877-z.

Temporal Trends and Factors Associated With Cardiovascular Drug Development, 1990 to 2012.

JACC Basic Transl Sci. 2016 Aug 29;1(5):301-308. doi: 10.1016/j.jacbts.2016.03.012. eCollection 2016 Aug.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验